1/2 IMPACt-LBP CCC-Administrative Supplements for Complementary Health Practitioner Research Experience
1/2 IMPACt-LBP CCC-补充健康从业者研究经验的行政补充
基本信息
- 批准号:10856432
- 负责人:
- 金额:$ 5.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-15 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:Administrative SupplementAdultAgeAmbulatory CareAmericanAmerican College of PhysiciansCaringCategoriesChronic low back painClient satisfactionClinicClinicalClinical ResearchClinical Trials DesignCluster randomized trialCollaborationsComplementary HealthData Coordinating CenterDoctor of ChiropracticDocumentationDrug PrescriptionsEmergency department visitExerciseFocus GroupsGoalsGuidelinesHealth Care CostsHealth systemHealthcare SystemsHospitalizationInfrastructureInjectionsInterventionInterviewIowaLow Back PainMeasuresMedicalMedical Care CostsMedical centerMethodsModelingMusculoskeletalOperative Surgical ProceduresOpioidOrganizational PolicyPainPain interferencePain managementPain qualityPatient CarePatientsPhasePhysical FunctionPhysiciansPoliciesPrimary CareProceduresProtocols documentationProviderQuality-Adjusted Life YearsRandomized, Controlled TrialsRecommendationReportingResearchResearch DesignResearch InstituteResourcesRiskSiteSourceSpinal FusionSpinal ManipulationStandardizationSurveysSymptomsSystemTestingTimeTrainingUniversitiesVisitWorkchronic painclinical painclinical research siteclinical trial protocolcollaborative carecomparative effectivenesscompare effectivenesscostdisabilityeffectiveness testingexperiencefunctional statusfuture implementationhealth care service utilizationhealth service useimplementation facilitationimplementation trialimprovedincremental cost-effectivenessinformantmembermultidisciplinaryopioid epidemicopioid mortalityopioid usepain reductionpain-related disabilityphysical therapistpragmatic studyprescription opioidprimary care providerprimary endpointprimary outcomeprocess evaluationrandomized, clinical trialssecondary outcomeservice utilizationtreatment as usualuptake
项目摘要
Low back pain (LBP) is a key source of medical costs and disability, impacting over 31 million Americans at
any given time and resulting in $100-$200 billion per year in total healthcare costs. LBP is one of the leading
causes of ambulatory care visits to US physicians; unfortunately, these visits often result in treatments such as
opioids that can lead to more harm than benefit. In 2017 the American College of Physicians (ACP) guideline
for LBP recommended patients receive non-pharmacological interventions as a first-line treatment but stopped
short of offering solutions regarding how such treatments should be integrated into routine patient care.
Roadmaps exist for multi-disciplinary collaborative care that includes doctors of chiropractic and physical
therapists, well-trained primary contact clinicians with specific expertise in the treatment of musculoskeletal
conditions, as first line providers for LBP. These clinicians routinely employ many of the non-pharmacological
approaches recommended by the ACP guideline, including spinal manipulation and exercise. Important
foundational work conducted by members of the study team has demonstrated that such care is feasible, safe,
and results in improved physical function, less pain, fewer opioid prescriptions, and reduced utilization of
healthcare services. However, this treatment approach for LBP has yet to be widely implemented or validated
using rigorous scientific methods. Our overarching goal is to refine and implement a multidisciplinary
collaborative care model for LBP (MC2LBP) in 3 academic Health Care Systems (HCS) and then evaluate its
effectiveness by comparing it to usual medical care in patients age 18 and older suffering from LBP.
Completion of project study aims will begin with a one-year UG3 planning phase involving completion of 22
milestones in 2 categories of phased activities - model implementation and clinical trial design. UH3 study aims
will be accomplished using a pragmatic, cluster-randomized, clinical trial design. The study will be managed
through a Clinical Coordinating Center and Data Coordinating Center, both housed at the Duke Clinical
Research Institute, in collaboration with Dartmouth-Hitchcock Medical Center and the University of Iowa.
During the planning phase, we will build implementation infrastructure across three HCS, finalize the clinical
trial protocol, and complete the tasks necessary to transition from the UG3 to UH3 phase. The UH3 phase will
be used to: 1) Operationalize the integration of new organizational policies and procedures required to facilitate
implementation of MC2LBP at intervention clinics; 2) Determine the comparative effectiveness of MC2LBP vs
usual care; 3) Estimate and compare medical resource use and costs of implementing MC2LBP; and 4)
Evaluate patient, provider, system and policy level barriers and facilitators to implementing MC2LBP, using a
mixed method, process evaluation approach. Results from this study have the potential to inform future
implementation and policy efforts to improve the quality of pain management for patients suffering from LBP
while simultaneously reducing opioid prescriptions, health care costs and utilization of services.
腰痛(LBP)是医疗费用和残疾的关键来源,影响了3100万美国人
任何给定的时间,每年的医疗保健总费用为100-2000亿美元。 LBP是领先的
向美国医生访问门诊护理的原因;不幸的是,这些访问通常会导致治疗
阿片类药物可能导致弊大于利。 2017年美国医师学院(ACP)指南
对于LBP,建议的患者接受非药物干预措施作为一线治疗,但停止了
除了提供有关如何将这种治疗纳入常规患者护理中的解决方案。
存在用于多学科协作护理的路线图,其中包括脊椎治疗和身体医生
治疗师,训练有素的初级接触临床医生,具有特定专业知识在治疗肌肉骨骼
条件,作为LBP的第一行提供商。这些临床医生通常使用许多非药理学
ACP指南推荐的方法,包括脊柱操纵和运动。重要的
研究小组成员进行的基础工作表明,这种护理是可行的,安全的,
并导致身体功能改善,减轻疼痛,更少的阿片类药物处方以及减少的利用率
医疗服务。但是,这种LBP治疗方法尚未得到广泛实施或验证
使用严格的科学方法。我们的总体目标是完善和实施多学科
LBP(MC2LBP)3个学术保健系统(HCS)的协作护理模型,然后评估其
通过将18岁及以上患者患有LBP的患者的常规医疗服务进行比较,有效。
项目研究目标的完成将从一年的UG3计划阶段开始,涉及完成22
两类分阶段活动的里程碑 - 模型实施和临床试验设计。 UH3研究的目的
将使用务实的,簇的临床试验设计来完成。该研究将进行管理
通过临床协调中心和数据协调中心,都位于杜克临床
研究所与达特茅斯 - 希区柯克医学中心和爱荷华大学合作。
在计划阶段,我们将跨三个HC构建实施基础设施,最终确定临床
试验协议,并完成从UG3过渡到UH3阶段所需的任务。 UH3阶段将
用于:1)操作促进的新组织政策和程序的集成
在干预诊所实施MC2LBP; 2)确定MC2LBP与
通常的护理; 3)估计和比较医疗资源的使用以及实施MC2LBP的成本;和4)
评估患者,提供者,系统和政策级别的障碍以及实施MC2LBP的促进者
混合方法,过程评估方法。这项研究的结果有可能告知未来
实施和政策努力,以改善患有LBP患者的疼痛管理质量
同时减少阿片类药物处方,医疗保健成本和服务利用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Adam Goode其他文献
Adam Goode的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Adam Goode', 18)}}的其他基金
1/2 IMPACt-LBP CCC-Administrative Supplements for Complementary Health Practitioner Research Experience
1/2 IMPACt-LBP CCC-补充健康从业者研究经验的行政补充
- 批准号:
10710788 - 财政年份:2023
- 资助金额:
$ 5.82万 - 项目类别:
Preventing Disability from MSK Pain in Northern Tanzania
预防坦桑尼亚北部 MSK 斯隆疼痛造成的残疾
- 批准号:
10264053 - 财政年份:2020
- 资助金额:
$ 5.82万 - 项目类别:
Biomarkers to Advance Clinical Phenotypes of Low Back Pain (BACk)
促进腰痛 (BACk) 临床表型的生物标志物
- 批准号:
9445928 - 财政年份:2017
- 资助金额:
$ 5.82万 - 项目类别:
Biomarkers to Advance Clinical Phenotypes of Low Back Pain (BACk)
促进腰痛 (BACk) 临床表型的生物标志物
- 批准号:
9755361 - 财政年份:2017
- 资助金额:
$ 5.82万 - 项目类别:
Biomarkers to Advance Clinical Phenotypes of Low Back Pain (BACk)
促进腰痛 (BACk) 临床表型的生物标志物
- 批准号:
10735846 - 财政年份:2017
- 资助金额:
$ 5.82万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Assessing the real-world impact of a low nicotine product standard for smoked tobacco in New Zealand
评估新西兰低尼古丁产品标准对吸食烟草的现实影响
- 批准号:
10665851 - 财政年份:2023
- 资助金额:
$ 5.82万 - 项目类别:
Stroke Connectome MRI biomarkers for VCID risk assessment
用于 VCID 风险评估的中风连接组 MRI 生物标志物
- 批准号:
10887028 - 财政年份:2023
- 资助金额:
$ 5.82万 - 项目类别:
Developing a culturally adapted implementation program for teleophthalmology use in Latinx communities
制定适合拉丁裔社区远程眼科使用的文化适应实施计划
- 批准号:
10771837 - 财政年份:2023
- 资助金额:
$ 5.82万 - 项目类别:
Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN)Scientific Leadership Center; ADMIN SUPPLEMENT
艾滋病毒/艾滋病干预青少年医学试验网络 (ATN) 科学领导中心;
- 批准号:
10855435 - 财政年份:2023
- 资助金额:
$ 5.82万 - 项目类别:
Multi-Channel Communication for Improvements in Cancer Education and Outcomes (MICEO) in Underserved Populations
多渠道沟通以改善服务不足人群的癌症教育和结果 (MICEO)
- 批准号:
10892444 - 财政年份:2023
- 资助金额:
$ 5.82万 - 项目类别: